Introduction Before the global mpox outbreak which began in 2022, the real-world vaccine
effectiveness (VE) of mpox vaccines was unknown. We quantified the VE in the global …

Background Historically, human mpox was predominantly a zoonotic disease occurring
more frequently in rural children in Africa and characterized by a largely self-limiting febrile …

Pathogen genome sequencing during epidemics enhances our ability to identify and
understand suspected clusters and investigate their relationships. Here, we combine …

Background The serial interval is the period of time between symptom onset in the primary
case and symptom onset in the secondary case. Understanding the serial interval is …

Background With more than 7500 cases reported since April 2022, Spain has experienced
the highest incidence of mpox in Europe. From 12 July onward, the modified vaccinia …

Background Tracking infectious diseases at the community level is challenging due to
asymptomatic infections and the logistical complexities of mass surveillance. Wastewater …

Mpox has spread rapidly to many countries in nonendemic regions. After reviewing detailed
exposure histories of 109 pairs of mpox cases in the Netherlands, we identified 34 pairs …

Incidence of human monkeypox (mpox) has been increasing in West and Central Africa,
including in the Democratic Republic of Congo (DRC), where monkeypox virus (MPXV) is …

Monkeypox (mpox), a former rare viral zoonosis, has increasingly made it into the public eye
since the major outbreak that started in May 2022. Mpox presents with skin lesions that …

In June of 2022, the US Centers for Disease Control and Prevention (CDC) Mpox Response
wanted timely answers to important epidemiological questions which can now be answered …